<DOC>
	<DOCNO>NCT00525252</DOCNO>
	<brief_summary>Intervention achieve alcohol abstinence represent effective treatment alcoholic patient liver cirrhosis . However trial evaluate efficacy anti-craving drug patient concern medication might worsen liver disease . Baclofen effective reduce alcohol crave improve abstinence alcohol-dependent patient . It mainly eliminate kidney . No hepatic side-effects report treated patient . The present study investigate efficacy safety baclofen achieve maintain abstinence alcoholic cirrhotic patient .</brief_summary>
	<brief_title>Efficacy Baclofen Treatment Alcohol Addiction</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Cirrhosis , Alcoholic</mesh_term>
	<criteria>age range 18 75 year diagnosis alcohol dependence accord DSM IV criterion diagnosis liver cirrhosis alcohol intake least 2 heavy drinking day ( men &gt; 5 drinks/days ; woman &gt; 4 drinks/day ) per week , average average overall consumption 21 drinks/week men 14 drinks/week woman 4 week prior enrolment presence refer family member severe heart lung disease kidney alteration and/or hepatorenal syndrome tumour , include hepatocellular carcinoma metabolic disease , include diabetes clinical sign hepatic encephalopathy patient treat interferon corticosteroid within last 60 day psychopathological illness undergoing treatment psychoactive drug epilepsy epileptiform convulsion addiction drug nicotine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Liver cirrhosis</keyword>
	<keyword>Alcoholism</keyword>
	<keyword>Craving</keyword>
</DOC>